|Publication number||US7166125 B1|
|Application number||US 09/686,264|
|Publication date||23 Jan 2007|
|Filing date||10 Oct 2000|
|Priority date||9 Mar 1988|
|Also published as||US6860901, US20070179591|
|Publication number||09686264, 686264, US 7166125 B1, US 7166125B1, US-B1-7166125, US7166125 B1, US7166125B1|
|Inventors||Steven G. Baker, Dinah B. Quiachon, Alec A. Piplani, Wesley D. Sterman, Ronald G. Williams|
|Original Assignee||Endovascular Technologies, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (66), Non-Patent Citations (18), Referenced by (119), Classifications (31), Legal Events (6)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation of application Ser. No. 08/485,481, filed Jun. 7, 1995, now U.S. Pat. No. 6,221,102 which is a continuation-in-part of application Ser. No. 109,162 filed Au. 19, 1993, which is a divisional of application Ser. No. 553,530 filed Jul. 13, 1990, now U.S. Pat. No. 5,275,622, which is a continuation-in-part of application Ser. No. 166,093 filed on Mar. 9, 1988, now U.S. Pat. No. 5,104,399, which is a continuation-in-part of application Ser. No. 08/940,907 filed Dec. 10, 1986, now U.S. Pat. No. 4,787,899, which is a continuation of application Ser. No. 559,935, filed on Dec. 9, 1983, now abandoned. The contents of each of theses applications are hereby incorporated by reference.
This application relates to endovascular grafting apparatus, system and method and devices for use therewith.
The state of the art is described in the background of the invention in U.S. Pat. No. 5,104,399.
In general, it is an object of the present invention to provide an endovascular grafting apparatus, system and method and devices for use therewith which overcome the disadvantages of the prior art apparatus, systems and devices.
Another object of the invention is to provide an apparatus and system of the above character which utilizes a pusher rod assembly which is constrained so that relatively great forces can be applied by the pusher rod assembly.
Another object of the invention is to provide an apparatus and system of the above character in which the capsule is flexible so that it can negotiate bends in the vessels of a patient.
Another object of the invention is to provide a grafting apparatus and system which utilizes a flexible capsule which can contain a graft with hook-like elements without any danger of the hook-like elements penetrating the capsule.
Another object of the invention is to provide an apparatus and system of the above character in which the graft automatically springs into an open or expanded position when it is released from the capsule.
Another object of the invention is to provide an apparatus, system and method of the above character in which a pushing force is applied to the distal extremity of the balloon for advancing a graft out of the capsule.
Another object of the invention is to provide an apparatus and system of the above character in which a fixed wire or an over-the-wire guide wire system can be used.
Another object of the invention is to provide an apparatus and system of the above character in which the graft can be compressed to a very small size in a flexible capsule.
Additional objects and features of the invention will appear in the following description in conjunction with the accompanying drawings.
Another feature of the present invention is a novel attachment system that comprises a sinusoidal wire frame and V-shaped lumen piercing members. The sinusoidal frame has two ends and alternating base apices and protruding apices. The protruding apices protrude outward and are mounted onto the graft to extend outward past the end of the graft. The base apices are oriented inside the lumen of the graft and points inward from the end of the graft. The portion of the wire frame connecting the protruding apices to the base apices are struts.
In one embodiment, the two ends of the wire frame are welded together to obtain circular continuity of the wire frame. In another embodiment, the wire frame has one additional protruding apex and the ends of the wire frame terminate in helices generally aligned with the base helices. The frame is mounted by overlapping the two ends of the wire including a pair of protruding apices adjacent the end. The wire frame is sewn to the body of the graft at various points over the entire wire frame. The lengths of the struts may be adjusted to stagger the apices so that the profile of the wire frame and the graft can be minimized to fit into a smaller delivery capsule.
In addition to the wire frame, the attachment system further includes a plurality of lumen piercing members affixed to the struts. The lumen piercing members are configured to protrude radially outward from the attachment system to engage the lumen wall of a blood vessel and secure the graft in place to prevent migration of the graft along the blood vessel. The lumen piercing member of one embodiment includes a wire arm that has an outwardly protruding hook constructed of stainless steel wire. The hooks are aligned with and welded to the struts of the wire frame.
Another embodiment of the lumen piercing members eliminates the need for welds to secure the lumen piercing members to the graft. Each lumen piercing member is bent into a V-shape and each have an apex and two arms that extend in a direction parallel to the struts of the wire frame. The arms terminate in radially outward protruding hooks that are configured to engage the wall of the vessel. The lumen piercing member is secured to the graft in close proximity to the wire frame and is responsive to the outward bias of the wire frame.
Another embodiment of the attachment system of the present invention configured for use in the iliac arteries in a bifurcated graft includes two sinusoidal wire frames that have alternating base apices and protruding apices. Each of the iliac wire frames have two end arms that extend longitudinally outward to engage the iliac artery wall. The wire arms are configured as lumen piercing members which extend as struts from the end base apices. The two wire frames are joined together by overlying the end base apex of one of the wire frames with the end base apex from the other wire frame such that each of the wire arms extend parallel to an adjacent strut. The end arms are twisted around the adjacent struts and bent behind the protruding strut that is integrally connected to the adjacent strut. The ends of the lumen piercing member is hook-like to securely engage the vessel wall. The hooks are secured to the vessel wall when an additional radially outward force presses the vessel into the lumen wall, such as from a deployment balloon.
Another feature of the present invention includes a device to substantially eliminate leaks around the perimeter of the graft at the ends where the attachment system engages the lumen wall. The outside of the graft is textured with a plurality of filaments or fibers that are spun, woven, knotted, pressed or otherwise loosely associated to form a puffed textured filler or tuft that is sewn to or affixed to the outside of the graft proximal to the end of the graft. The ends of the fibers may be frayed to increase the surface area of the tuft. Alternatively, strands of loosely spun synthetic yarn are cross-stitched around the perimeter of the graft proximate the attachment system.
Another feature of the present invention includes a graft that is crimped radially along at least a portion of the length of the graft. The crimps form a generally corrugated tubular surface defining a plurality of radially outwardly protruding ribs that are separated longitudinally by alternating inwardly directed folds or pleats. The crimping occurs along the length of the graft between the two attachment systems. The crimping may be configured over the entire length or over only a portion of the graft.
Other features and advantages of the present invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawings, which illustrate, by way of example, the principles of the invention.
In general, the endovascular grafting system is comprised of a capsule catheter having a flexible elongate tubular member with proximal and distal extremities and a capsule mounted on the distal extremity of the tubular member. The capsule is generally cylindrical in shape and is formed of a helical wraps of a metal ribbon. Means is provided for bonding said wraps into a unitary capsule while permitting bending of said unitary capsule. A graft is disposed within the capsule. The graft is comprised of a tubular member having proximal and distal ends. Hook-like attachment means is secured to the proximal and distal ends of the tubular member and face in a direction outwardly towards the inner wall of the capsule. Push rod means is disposed within the capsule catheter and engages the graft whereby upon relative movement between the push rod means and the capsule catheter, the graft can be forced out of the capsule.
More in particular, the endovascular grafting apparatus and system 11 and the devices for use therein are shown in
An inner liner 17 is mounted within the tubular member 16. The liner 17 is sized so that it will fit within the tubular member 16. The liner is preferably formed of a lubricous material such as Tefzel (ethylene tetrafluoroethylene) or Teflon FEP (fluorinated ethylene polypropylene). It can have an inside diameter of 0.085 inches and an outside diameter of 0.125 inches and a length as, for example, 41 centimeters which is slightly less than that of the tubular member 16. If desired, the inside diameter of the liner 17 can be in the range of 0.075 to 0.120 inches. The liner 17 is provided with a lumen 18 which extends the length thereof. The liner 17 reduces the inside diameter of the lumen 18 for a purpose hereinafter described. The liner 17 is made of a radiation stable material so that the catheter can be radiation sterilized. Tefzel, or Teflon FEP, which is a polymer is such a radiation sterilizable material. The inner liner 17 also serves to provide additional columnar strength to the catheter 12.
A wye adapter 21 is secured to the proximal extremity of the flexible tubular member 16. The side arm 22 of the adapter 21 has a stop cock 23 mounted therein which is movable between open and closed positions. The stop cock 23 is provided with a Luer fitting 24 which is adapted to be secured to a syringe which can be utilized for injecting a dye, or medications such as a vasodilator.
As shown in
The capsule catheter 12 has a capsule 36 incorporating the present invention mounted on the distal extremity of the flexible elongate tubular member 16. The capsule 36 when used in humans has a diameter ranging from 4 to 8 millimeters. The flexible elongate tubular member 16 which also serves as a shaft for advancing the capsule 36 as hereinafter described and should have a diameter which is less than that of the capsule and therefore has an outside diameter ranging from 3 to 7 millimeters.
The capsule 36 is a composite structure and is formed of an inner layer 37 and an outer layer 38. The inner layer 37 is formed of a stainless steel ribbon 39 with the ribbon having a width of 0.150 inches and a thickness ranging from 0.002 to 0.004 inches and preferably approximately 0.003 inches. The ribbon is spiral wound on a mandrel (not shown) so that each wrap of the ribbon overlaps the preceding wrap by approximately 30 to 50% of the width of the ribbon. viewing the capsule 36 from the left hand end, the ribbon is wrapped in a clockwise or counterclockwise direction so that the edges 41 face distally or in the direction which is toward the right as shown in
In order to prevent elongation of the capsule 36 and also to prevent one wrap separating from another of the inner layer 37, a plurality of elongate flexible strands 43 are provided which extend from one end to the other of the capsule. It has been found that the use of four strands has been sufficient with the strands being spaced apart circumferentially by 90°. The strands 43 can be formed of a suitable material such as a Kevlar aramid fiber, 195 denier. These four strands 43 are bonded to the proximal and distal extremities of the capsule by a suitable adhesive such as a cyanoacrylate ester at points 44. The outer layer 38 which overlies the strands 43 and the wrapped ribbon inner layer 37 is in the form of a jacket formed of a suitable material such as heat shrinkable polyethylene. This jacket can have a wall thickness ranging from 0.001 to 0.006 inches and preferably a thickness of approximately 0.004 inches. The polyethylene jacket which forms the outer layer 38 serves to contain the Kevlar strands 43 in close proximity to the inner layers 37 and also serves to prevent elongation of the capsule 36 while permitting the capsule to bend during use as hereinafter described. The outer layer or jacket 38 serves also to provide a smooth surface for the exterior of the capsule 36 by enclosing the edges 41 of the wraps of ribbon 39. In addition, the proximal and distal extremities of the capsule 36 are bonded together by a solder in the regions 46 as indicated in FIG. 2. The solder can be of a suitable type, such as a tin silver solder comprised of 95% tin and 5% silver. When constructed in this manner, the capsule 36 can have an inside diameter of 0.175 inches to 0.300 inches with a nominal wall thickness of 0.0012 inches.
The capsule 36 is secured to the distal extremity of the flexible elongate tubular member 16 by a capsule adapter 51 of a suitable material such as a polycarbonate. The capsule adapter 51 is secured in the proximal extremity of the capsule 36 by suitable means, as a press fit or alternatively, in addition, by the use of a suitable adhesive such as a cyanoacrylate ester. The other extremity of the capsule adapter 51 is also mounted in a suitable manner such as by a cyanoacrylate ester adhesive to the distal extremity of the flexible elongate tubular member 16. The capsule adapter 51 is provided with a hole 52 of a suitable diameter such as 1/16th of an inch.
The capsule 36 made in accordance with the present invention has a number of desirable features. It is particularly desirable because it is flexible and can be bent through an angle of 70 to 120° in a length of 8-20 centimeters. In order to prevent hangups on the inside edges 41 of the ribbon, the inside edges are rounded and polished, preventing damage to capsule contents during ejection as hereinafter described. The Kevlar strands 43, which are also contained by the outer jacket or layer 38, serve to maintain the wrap, prevent stretching or elongation and prevent discontinuities from being formed in the capsule during use of the same. In addition, the Kevlar strands prevent the capsule from being flexed beyond a predetermined angle, as, for example, 120°.
Thus, it can be seen that a capsule 36 has been provided which is very flexible, yet is still very hard and has great strength which inhibits crushing or collapsing while being bent or flexed. In other words, it is kink resistant. It is also puncture proof due to the use of the metal ribbon 37. The capsule 36 is semi-radiopaque and is radiation sterilizable.
As shown in
A separate balloon 64 formed of suitable material such as polyethylene is secured to the distal extremity of the flexible elongate member 62 in a manner hereinafter described. A pusher button 66 is provided which is formed of a suitable material such as 300 series stainless steel. The pusher button 66 can have a diameter ranging from 0.120 inches to 0.200 inches and preferably an outside diameter of approximately 0.140 inches. Stainless steel is utilized to achieve radiopacity.
The pusher button 66 is mounted on a fixed position on the catheter shaft 62 and is spaced a predetermined distance from the proximal extremity of the balloon 64 as, for example, a distance of 2 to 3 centimeters. The pusher button 66 is retained in this position longitudinally of the shaft 62 by annular bulbs 67 and 68 which are formed by localized heating in those areas of the shaft 62 which causes it to expand radially in an attempt to achieve its original size to trap the pusher button 66 in that position to the shaft 62. Thus, it can be seen that the pusher button 66 can be mechanically trapped in place without the use of an adhesive and without changing the size of the lumen 63 which extends therethrough.
An alternative embodiment in which the pusher button 66 is movable between the proximal extremity of the balloon 64 and a single bulb 67 is shown in FIG. 4.
A small stainless steel tube 69 is disposed within the balloon 64 and has its proximal extremity seated within the distal extremity of the shaft or flexible elongate member 62. The tube 69 has a suitable inside diameter such as 0.022 inches, an outside diameter of 0.032 inches and a suitable length as, for example, 7.5 centimeters. As can be seen from
A very flexible guide wire 74 is secured to the distal extremity of the balloon 64. The guide wire can have a suitable diameter such as 0.052 inches in outside diameter and can have a suitable length, as for example, 7 centimeters. The guide wire 74 can be a spring formed from wire having a suitable diameter such as 0.009 inches so that it will be radiopaque and thus readily observable under x-rays when being used. The guide wire is provided with a rounded tip 76 which can be formed from a suitable material such as a tin silver solder of 95% tin and 5% silver. The solder tip 76 has bonded therein the distal extremity of a safety ribbon 77 which extends towards the proximal extremity of the spring guide wire 74 and is secured to the proximal extremity thereof by suitable means such as the same tin silver solder hereinbefore described. The guide wire 74 can range in diameter from 0.036 inches to 0.060 inches. The ribbon 77 can be formed of a suitable material such as stainless steel and have a thickness of 0.003 inches and a width of 0.010 inches.
As can be seen from
The guide wire 74 is easily observed using x-rays due to its width and stainless steel composition. Since the pusher button 66 is also formed of stainless steel, it also is an easy marker to follow. The pusher button 66 and guide wire 74 help indicate the position of the balloon 64 because the balloon 64 is positioned between the pusher button 66 and the guide wire 74. The balloon 64 itself can be observed under x-rays because the blood in the patient's vessel is more opaque than the gas used for inflating the balloon. However, increased visibility of the balloon 64 can be obtained by inflating the balloon 64 with a diluted radiopaque contrast solution. In addition, if desired as shown in
It should be appreciated that although a separate balloon 64 has been provided, if desired, an integral balloon can be provided which is formed of the same tubing from which the flexible elongate tubular member 62 is made. This can be readily accomplished, as is well known to those skilled in the art, by using an additional radiation dose for the balloon region of the tubing.
The endovascular grafting apparatus also includes a pusher rod assembly 96 which is shown in FIG. 7. It consists of a rigid thin wall tube 97 formed of a suitable material such as stainless steel. It has a suitable length as, for example, 21 centimeters and has an outside diameter of 0.065 inches and an inside diameter of 0.053 inches. An elongate solid flexible wire 98 of a suitable diameter as, for example, 0.018 inches is provided which extends centrally into the bore 99 of the tube for the entire length of the rigid tube 97. The wire 98 is secured by suitable means such as an adhesive into a male Luer cap 101 mounted on the proximal end of the tube 97.
Reference is made to
An alternative pusher rod assembly 106 is shown in
An alternative embodiment of a pusher rod assembly 116 cooperating with the balloon catheter assembly 81 shown in
The endovascular grafting apparatus 11 also includes an expandable intraluminal vascular graft 121 shown in
The spring means 131 is secured to the first and second ends 123 and 124 of the tubular member by suitable means such as Dacron polyester suture material 146 which is utilized for sewing the spring means onto the tubular member. This can be accomplished by a sewing operation with the suture material 146 extending into and out of the wall 126 of the tubular member and in which knots 147 are formed on each of the legs or struts 137 and 138 in such a manner so that the apices lying in the plane 141 extend outwardly and are spaced from the end on which they are mounted and in which the apices lying in the plane 142 extend just beyond the outer edge of the tubular member and in which the apices in the third plane are positioned inwardly from the outer edge.
Hook-like elements 151 are provided on the apices lying in planes 141 and 142 and are secured to the vees 132 in the vicinity of the apices by suitable means such as welding. The hook-like elements 151 can have a suitable diameter such as 0.010 to 0.14 inches and a length from 0.5 to 3 millimeters. The hook-like elements are sharpened to provide conical tips. The hook-like elements 151 should have a length which is sufficient for the hook to penetrate into the vessel wall, but not through the vessel wall.
The spring means 131 with the hook-like elements 151 secured thereto are formed of a corrosion resistant material which has good spring and fatigue characteristics. One such material found to be particularly satisfactory is Elgiloy which is a chromium-cobalt-nickel alloy manufactured and sold by Elgiloy of Elgin, Ill. The wire can have a diameter ranging from 0.010 to 0.015 inches in diameter with the smaller diameter wire being utilized for the smaller diameter tubular members as, for example, 12 to 15 millimeters in diameter and the larger tubular members as, for example, those having a 30 millimeter diameter using the larger wire sizes.
It has been found that the spring force created by the helical coils 136 at the apices 133 is largely determined by the diameter of the wire. The greater the diameter of the wire, the greater the spring force applied to the struts or legs 137 and 138 of the vees. Also, the longer the distances are between the apices lying in planes 141 and 142, the smaller the spring force that is applied to the legs or struts 137 and 138. It therefore has been desirable to provide a spacing between the outer extremities of the legs or struts of approximately one centimeter, although small or larger distances may be utilized.
The hook-like elements 151 at the proximal and distal extremities of the graft 121 are angled at suitable angles with respect to longitudinal axis of the tubular member 122. The hook-like elements face towards each other to facilitate holding the graft 121 in place in the vessel of the patient. Thus, the hook-like elements 151 on the proximal extremity 123 are inclined from the longitudinal axis by 55° to 80° and preferably about 65° toward the distal end of the graft 121 in the direction of blood flow. The hook-like elements 151 on the distal end 124 of the graft or implant 121 are inclined from the longitudinal axis by 30° to 90° and preferably 85° in a direction towards the proximal end 123 and opposite the direction of blood flow. The hook-like elements 151 serve as attachment means at each end of the graft 121 and when implanted oppose migration of the graft.
The helical coil springs 136 placed at the nodes or apices 133 of the vees 132 of the spring means 131 serve to facilitate compression of the graft when it is desired to place the same within the capsule 36 as hereinafter described. The compression of the graft is accomplished by deformation of the coil springs 136 within their elastic limits. Placing the nodes or apices 133 in different planes greatly aids in reducing the size to which the graft can be reduced during compression of the same by staggering or offsetting the hooks or hook-like elements 151. This also helps to prevent the hook-like elements from becoming entangled with each other. The natural spring forces of the helical coil springs 136 provided in the apices of the vees serves to expand the graft to its expanded position as soon as the graft is free of the capsule 36 (FIG. 1). By way of example, as shown in the drawings, three apices or nodes can be provided in the plane 141 and three apices or nodes in the plane 142 which are offset longitudinally with respect to the nodes in plane 141 and six nodes in plane 143. The placement of six nodes or apices 133 in the plane 143 does not interfere with the compression of the graft 151 because there are no hook-like elements 151 at these nodes or apices 133 in the plane. For larger diameter grafts, the spring means 131 can be provided with additional apices or nodes 133 to enhance attachment as hereinafter described.
Radiopaque marker means is carried by the graft 121. The radiopaque marker means takes the form of four radiopaque markers 156. The radiopaque markers are made of a suitable material such as a platinum tungsten alloy wire of a suitable diameter such as 0.003 inches which is wound into a spring coil having a diameter of 0.040 inches and having a length of 0.125 inches. These markers 156 are secured to the tubular member 122 by the same suture material 146. Two of the radiopaque markers 156 are located on the tubular member 122 in spaced apart aligned positions longitudinally of and parallel to the longitudinal axis of the tubular member 122 but are adjacent to the apices 133 lying in the planes 143 at the opposite ends 123 and 124 of the graft 121. Thus the markers 156 are spaced a maximum distance apart on the graft but still within the attachment means carried by the graft 121. Another set of two markers is provided on the tubular member 122 spaced 180° from the first set of two markers along the same longitudinal axis (see FIG. 15). By placing the markers in these positions, it is possible to ascertain the position of the graft 121 and at the same time to ascertain whether or not there has been any twist in the graft between the first and second ends of the graft. In other words when there is no twist in the graft 121 the four markers 156 form four corners of a rectangle. However, if a twist in the graft 121 is present, then the pair of markers 156 at one end of the graft 121 have a different spacing transverse of the longitudinal axis of the graft then the other pair of markers 156 at the other end.
In order to ensure that the graft 121 will not become dislodged after it has been implanted, it may be desirable to provide alternative hook-like elements to ensure that the graft will remain in place after it has been implanted. An alternative hook-like element 161 is shown in
Another alternative hook-like element 166 is shown in
The endovascular grafting apparatus 11 is shown assembled for use as shown in
When it is desired to perform a procedure utilizing an endovascular grafting apparatus or system 11 of the present invention to perform the method of the present invention, an apparatus is selected which has the appropriate size of graft 121 within the capsule 36. The length and size of the graft 121 is determined by the size of the vessel of the patient in which the aneurysm has occurred. Typically the size of the graft 121 is selected so that it has sufficient length to span approximately one centimeter proximal and one centimeter distal of the aneurysm so that the hook-like elements 151 of the graft can seat within normal tissue of the vessel on both sides of the aneurysm. Thus, the graft should be two centimeters longer than the aneurysm being repaired. The diameter is selected by measuring the vessel in a preimplant procedure by conventional radiographic techniques and then using a graft 121 of the next larger one millimeter size. During the preimplant fluoroscopy procedure, using a conventional pigtail catheter, the locations of the renal arteries are ascertained so that they will not be covered by the graft 121 when it is implanted.
Let it be assumed that the patient on whom the operation is to take place has been prepared in a conventional manner by use of a dilator with a guide wire and a sheath (not shown) to open the femoral artery or vessel of the patient. The apparatus 11 is inserted into the sheath which has previously been placed in the femoral artery of the patient. This insertion can be accomplished without a guide wire, with a guide wire or by the use of a soft sheath previously positioned over a guide wire. With the construction shown in
Typically a desired position will be within the abdominal aorta with the proximal extremity 123 of the graft 121 and at least one centimeter distal to the lower renal artery. At about the same time, the physician should rotate the capsule catheter 12 to rotate the capsule 36 and the graft therein in order to orient the radiopaque graft markers 156 such that the distance between the pair of markers 156 at each end of the graft 121 is maximized. As soon the capsule 36 is in the desired position, the Touhy Borst O-ring assembly 27 is opened to permit free movement of the pusher rod assembly 96. With the balloon 64 riding well beyond or just distal of the end of the capsule 36, one hand of the physician is used for holding the pusher rod assembly between the pusher rod assembly 96 by engaging the cap 101 and holding the pusher rod stationary and pulling outwardly on the capsule catheter 12 with the other hand to cause relative movement between the pusher rod assembly 96 in the inner liner 17 and the capsule 36. This causes the wire 98 of the pusher rod assembly 96 to engage the plug 78 of the balloon catheter assembly 61. The pusher button 66 carried by the balloon catheter shaft 62 which is in engagement with the proximal extremity of the graft 121 in the region of the nodes 133 in the plane 143 forces the graft 121 out of the capsule 36 as the capsule is withdrawn. As soon as the proximal extremity of the graft has cleared the distal extremity of the capsule the proximal extremity 123 of the graft 121 pops outwardly under the force of the spring means 131 carried by the proximal extremity 123 of the graft 121 and will spring into engagement with the vessel wall 166.
As soon as this has occurred, the pusher rod assembly 96 (
As soon as this has been accomplished, the capsule catheter 12 is pulled out further with the balloon 64 still inflated until approximately one-half or more of the graft 121 has cleared the capsule 36. Leaving the balloon inflated provides additional security to ensure that the proximally seated graft 121 will not move during retraction of the capsule 36. The balloon 64 is then deflated. The balloon 64 is then retracted further into the graft and reinflated to ensure that a good attachment is made between the hook-like elements 151 carried by the spring means 131 at the proximal extremity 123 of the graft 121. The capsule 36 can then be removed in successive steps and the balloon deflated, retracted and reinflated. The capsule catheter 12 can then be withdrawn completely to the distal portion of the abdominal aorta to permit the distal extremity 124 of the graft 121 to move out completely of the capsule 36 and to permit its distal extremity 124 to spring open and have the hook-like elements 151 move into engagement with the vessel wall 166. Thereafter, the balloon 64 is again deflated. The balloon catheter shaft is then grasped by the physician's hand and pulled rearwardly to center the balloon 64 within the distal extremity 124 of the graft 121. The balloon 64 is reinflated to set the hook-like elements 151 at the distal extremity of the graft into the vessel wall 166. As soon as this has been completed, the balloon 64 is again deflated. The balloon catheter assembly 61 is then removed from the femoral artery.
The entire procedure hereinbefore can be observed under fluoroscopy. The relative positioning of the graft 121 and the balloon 64 can be readily ascertained by the radiopaque attachment means 131, radiopaque markers 156 provided on the graft, and the radiopaque portions of the balloon 64. If any twisting of the graft 121 has occurred between placement of the proximal hook-like elements and the distal hook-like elements, this can be readily ascertained by observing the four markers 156. Adjustments can be made before ejection of the distal extremity 124 by rotation of the capsule catheter 12 to eliminate any twisting which has occurred. In addition, the distance between the pairs of radiopaque markers 156 longitudinal of the axis is measured on the flat plate abdominal x-ray made during the procedure and compared with the known distance between the pairs of markers 156 longitudinal of the axis of the graft 121 ascertained during manufacture of the graft 121. This is done to ascertain whether longitudinal according of the graft 121 has occurred.
Post implant fluoroscopy procedures can be utilized to confirm the proper implantation of the device by the use of a conventional pigtail catheter. Thereafter the sheath can be removed from the femoral artery and the femoral artery closed with conventional suturing techniques. Tissues should begin to grow into the graft within two to four weeks with tissue completely covering the interior side of the graft within six months so that no portion of the graft thereafter would be in communication with the blood circulating in the vessel. This establishes a complete repair of the aneurysm which had occurred.
It is apparent from the foregoing that there has been provided a new and improved endovascular grafting apparatus, system and method for utilizing the same. The construction of the capsule catheter is such that it has sufficient rigidity to ensure easy and ready placement of the capsule carried thereby. The pusher rod assembly which is used therein is constrained in such a manner so that relatively great forces can be applied to the pusher rod assembly even though the pusher wire has only a diameter of 0.018 inches. The tube 69 also serves to provide a confined space for the wire 98 to sit in while a high compressive force is being applied to the wire. The tube 69 prevents the wire from buckling or kinking within the balloon. It also prevents the balloon from collapsing during insertion of the apparatus 11. The capsule 36 which is provided as a part of the catheter assembly is formed of metal which makes it possible to utilize grafts having very sharp hook-like elements without any danger of then penetrating the capsule during the time that the capsule is being introduced into the vessel of the patient. In addition, the capsule since it is flexible and can bend through angles up to approximately 120° in order to readily negotiate the bends which occur in the vessel of the patient. The balloon catheter is made in such a way that the balloon can be readily introduced into the vessel because of the rigid tubular member provided within the balloon while at the same time permitting inflation and deflation of the balloon through the same tubular member. The pusher button 66 is mounted on the balloon catheter in such a manner so that it cannot shift at all in one direction or proximally longitudinally of the balloon catheter. The pusher button 66 also can only move a limited distance towards the balloon 64 until it reaches the balloon 64. In one embodiment shown in
The capsule 36 is constructed in such a manner so that it is semi-radiopaque allowing it to be visualized while still permitting observation of the graft within the capsule and the attachment means provided on the graft. The capsule 36 is also constructed in such a manner so that the hooks which are provided on the graft will readily slide in one direction over the wraps or turns of the capsule without hanging up or catching onto the individual wraps of the ribbon forming the capsule.
The graft which is provided with the helical coil springs at each of the nodes is particularly advantageous in that it permits compression of the graft into a very small size without causing permanent deformation of the attachment means. Because of the spring forces provided by the attachment means, it is possible that the grafts can be implanted without the use of an inflatable balloon for forcing the hook-like elements into the tissue of the vessel. However, at the present time, it is still believed to be desirable to utilize the balloon to ensure that the hook-like elements are firmly implanted into the wall of the vessel so as to inhibit migration of the graft within the vessel.
As shown in
The terms of reference such as radial, longitudinal, and lateral are defined in spacial relationship to the graft 206. For example, longitudinally outward represents a direction parallel to the axis of the graft outward from the middle of the graft to the end. Terms defining spacial relationships of the attachment system 200 are oriented relative to the graft when the attachment system is mounted into the graft. Thus a longitudinally outward protruding apex 216 is an apex that protrudes longitudinally outward from the graft.
Connecting each alternating apex 214 and 216 are struts 212. The wire frame is made of a stainless spring steel or metal alloy with a high amount of resilience or spring. An example of a preferred wire found to be useful is “ELGILOY” brand cobalt-chromium-nickel alloy manufactured and sold by Elgiloy of Elgin, Ill. The struts are each connected to a protruding apex 216 and a base apex 214. Each apex is connected by a pair of struts that define an angle between such pair of struts.
As illustrated in
The sinusoidal shape is retained when there are an equal number of base apices and protruding apices. The apex closest to the first end 208 is a protruding apex and is referred to herein as the first end apex 218. The apex closest to the second end 210 is a base apex and is referred to herein as the second end apex 220. Extending from the first apex to. the first end is a first partial strut 222. The strut extending from the second apex to the second end is the second partial strut 224. The first and second partial struts are aligned but point in opposite directions. The length of the first and second partial struts are predetermined to permit overlap of the ends and are equal in length so that the portion of the respective struts that overlap are equidistance from the first and second end apices. The first and second partial struts are welded at a point 226 equidistant from the first and second end apices. Once welded together, the first and second partial struts act as a single strut.
The struts 212 and apices, 214 and 216, are biased to create a radially outwardly directed force when the wire frame 202 is affixed to the inner perimeter of the graft 204. This is accomplished by compressing the struts together so that the angle between the struts generally are smaller than attached when the wire frame is permitted to relax to an equilibrium state. By compressing the struts the longitudinal profile of the attachment system decreases and the attachments system can be affixed to the inside of the graft. When affixed to the graft, the attachment system can relax and expand radially outward to bias the sides of the graft against the wall of the vessel.
The attachment system 200 further includes a plurality of lumen piercing members 228 affixed to the struts 212. The lumen piercing members are designed to protrude radially outward from the attachments system to engage the lumen wall of the blood vessel (not shown in
While the example of
Compression is observed in the triangular regions represented by numeral 244 at the top and bottom of the strut. Compression is caused when the molecular lattice of the wire is compressed together such that the wire molecules are closer together than if they were in no state of equilibrium. The force arrow 233 indicates the internal repulsion force that biases the wire towards its equilibrium state.
Tension is observed in the triangular regions indicated by reference numeral 246 on the top half and the bottom half of the strut. The tension results when the molecular lattice of the wire is pulled apart from its state of equilibrium. A force internal to the wire in the direction of force arrows 235 and 237 can be observed that biases the wire back to its original position.
With continued reference to FIG. 16 and
As the cardiac cycle begins, the blood vessel lumen contracts causing each strut 212 to bend slightly increasing the tension slightly along the top half of the strut and increasing the compression along the bottom half of the strut. Once the compression of the blood vessel reaches a maximum 262, the blood vessel relaxes causing the tension at the top of the strut 240 and the top of the weld 258 to decrease to a minimum. Likewise, the bottom of the strut 242 and the bottom of the weld 260 respond to the relaxation of the blood vessel with a decrease in the amount of compression to a minimum 264. The cardiac cycle becomes complete as the blood vessel again begins to constrict again causing an increase in the tension at the top of the strut and the top of the weld respectively, as well as a decrease in the compression at the bottom of the vessel. Throughout the cardiac cycle, the midpoint 238 defined as the point along the strut that is exactly equidistant between the protruding apex 216 at the top of the strut and the base apex 214 at the bottom of the strut. The compression of the upper portion of the graft and tension of the lower portion of the graft are equal in magnitude at any two given points that are equal distance from the midpoint throughout the entire cardiac cycle. Consequently, the magnitude of compression or tension remains constant absent any compression or tension throughout the cardiac cycle.
Observation of the compression and tension at various points along a strut 212 during the cardiac cycle reveals two important facts. First, the magnitude of compression or tension decreases along the strut toward the midpoint 238. Second, the differential between the magnitude of the maximum and minimum tension or compression during the cardiac cycle decreases along the length of the strut from the respective ends 240 and 242 to the midpoint. From a practical standpoint, the tension and compression contributes to metal fatigue of a wire spring and particularity to a weld 226. Consequently, metal fatigue of the weld is minimized when the weld is located as close to the midpoint of the strut as possible.
Another way of reducing the affect of metal fatigue is to create a wire frame 202 that has no welded parts.
To create an attachment system 200 without welds, the welded lumen piercing members 228 illustrated in
As shown in
The sinusoidal wire frame 202 is formed with nine outward protruding apices numbered A1 through A9 respectively beginning at the protruding apex A1 closest to the first end helix 266. Each of the apices are wound into a helical spring coil 270. Apex A1 and A9 are respectively the two apices that are closest to the first and second end helices. The alternating base apices are numbered for reference B1 through B8 beginning with the base apices closest to apex A1.
Each of the protruding apices A1 through A9 are integrally connected to adjacent base apices B1 through B8 by struts 212. As observed in
The helixes 270 located at outward protruding apices A1 through A8 are aligned slightly outward from the end of the graft 206. This accomplishes the purpose of minimizing the radial profile of the graft in collapsed position. The graft provides considerable bulk to the attachment system 200 and positioning the apices A1 through A8 beyond the end of the graft distributes longitudinally the bulk of the graft and helices. To further minimize the bulk of radial profile of the attachment system, the struts 212 that are adjacent to apex A9 are shortened slightly to offset apex A9 longitudinally inward from the end of the graft. Consequently, apex A9 when assembled and sewn into the graft is offset longitudinally inward from apex A1 and does not overly the same.
The helixes 270 located at the base apices B1 through B8 as well as the two end helices 266 and 268 respectively are staggered considerably. Apices B1, B3, B5, and B7 are configured with slightly larger diameter helices 276 to accommodate the lumen piercing members 274 which are bent into the shape of a vee. V-shaped lumen piercing members 274 will fit between the struts 278 adjacent to apices B1, B3, B5 and B7 in a close proximal relationship. The lengthened struts that connect the apices are sufficiently long to orient the apices B1, B3, B5 and B7 0.70 inches (17.8 mm) longitudinally inward from the protruding apices. Furthermore, the diameter of the enlarged helices 276 at apices B1, B3, B5, B7 are 0.63 inches (1.2 mm), which is considerably larger than the diameter of remaining smaller helices 282 formed in the wire frame 202. The smaller helices 282 have a diameter of 0.42 inches (1.1 mm). The enlarged helices 276, in combination with the lengthened struts 278, create a space between the struts 278 that extend longitudinally outward from the enlarged helices 276 formed in apices B2, B4, B6 and B8 that conform in shape to the V-shaped lumen piercing members 274 such that the lumen piercing members can fit into the attachment system in close proximity to the lengthened struts and the enlarged helices, without contacting or rubbing against the same.
Apices B2 and B6 may be further staggered with respect to apices B4 and B8. Apices B2 and B6 are oriented 0.46 inches longitudinally inward from the protruding apices. Apices B4 and B8 are oriented 0.36 inches longitudinally inward from the protruding apices. The first end helix 266 is also aligned 0.36 inches from the protruding apices.
As shown in
The wire frame 202 of the attachment system 200 illustrated in
The attachment system 200 including the wire frame 202 and the V-shaped lumen piercing members 274 are sutured to the graft 206 at various points throughout the graft. The sewing pattern can best be viewed with reference to
In the embodiment illustrated in of
Each hook forms an angle with its respective arm ranging from ninety degrees to forty five degrees, but preferably seventy (70) degrees as shown in
There are four pairs of V-shaped lumen piercing members 274 in the embodiment illustrated in
The hooks 292 have a length of two to three millimeters and are sharpened at the tips 302. The hooks may be sharpened with a conical tip 305 as shown in
One possible method of attaching the V-shaped lumen piercing members 274 to the frame can be observed with reference to
The V-shaped lumen piercing members 274 are mounted into the graft by pressing together the two arms 296 and 298 of the V-shaped lumen piercing members until the hooks are separated by a distance approximately equal to the outer diameter of the helices. The hooks are then punctured through the fibers of the graft from the outside 306 of the graft wall 206 to the inside 308 of the graft 308. The entry holes made by the V-shaped lumen piercing members are spaced longitudinally outward by more than the outer diameter of the helices 300 of the V-shaped lumen piercing members. The spacing apart of helices 300 of the V-shaped lumen piercing members prevents them from radially overlapping the enlarged base helices 276. This longitudinal spacing also furthers the goal of distributing the bulk of the attachment system 300 thereby narrowing the radial profile of the graft 206 when in a compressed state. The apices of the lumen piercing member, prior to insertion of the hooks through the graft, point outward towards the end of the graft. The two hooks should preferably be laterally aligned so that the entry holes 310 through the graft wall created by the hooks are laterally aligned. The V-shaped lumen piercing members are pressed through the puncture holes and slid inward along the arms until the helix 300 contacts the outer wall of the graft. The V-shaped lumen piercing members are inverted to an upright position thereby orienting the hooks radially outward to engage the wall of the blood vessel.
The arms 298 of the V-shaped lumen piercing members 274 are compressed before being sewn to the graft 206 to maintain the outward bias of the graft. The distance between the arms at the edge of the graft is preferably six to seven millimeters. The arms are sutured to the graft parallel to and in close proximal relationship to the struts 278 adjacent to the V-shaped lumen piercing members. The arms of the V-shaped lumen piercing members are generally not sutured directly to the adjacent struts. The arms of the V-shaped lumen piercing members and the adjacent struts are sutured separately in order to prevent them from rubbing together.
The attachment system 200 is inserted into a capsule (not shown). When the graft 206 is deployed to the appropriate location by a catheter delivery system (not shown), the graft is removed from the capsule. Immediately upon removal, the attachment system exerts a radially outward force on the wall of the graft biasing the graft against the wall of the vessel 198. The deployment balloon (now shown) is then used to further force the wall of the graft against the wall of the vessel and to cause the hooks 236 of the attachment system to pierce the vessel wall.
Leaking is also more likely to occur if the vessel is deformed. For example, the graft may have a slightly larger diameter than the inner dimension of the vessel or the vessel wall may not be smooth. In such circumstances, pleats in the graft are sometimes formed between the struts 212. Another factor that increases the likelihood of pleating is the pulsing of the blood vessel during the cardiac cycle as described above. When the blood vessel is contracted, pleating may be mildly accentuated.
The further prevention of leaks can be accomplished by texturing the outside of the graft 306 with a plurality of filaments or fibers that are spun, woven, knotted, pressed or otherwise loosely associated to form a puffed textured filler that can be sewn to or affixed to the outside of the graft proximal to the end of the graft. The filler of the embodiment illustrated in
A possible pattern of orienting the fibrous tufts 318 includes covering the graft 206 proximal to the perimeter of the attachment system with batting or by sewing loosely spun synthetic yarn such as polyester around the perimeter of the graft. Such a configuration would certainly fill all of the gaps that may arise. However, when considering the competing need of maintaining a narrow profile for the attachment system and graft in order to fit the attachment system into a capsule, the more spatially conservative approach of using tufts may be preferred.
A second and third row of tufts 326 are respectively sewn to the graft 206 near the base apices. The second row of tufts 324 are two to five millimeters longitudinally outward from the base apices B2, B4, B6, and B8. The second row has eight tufts and each tuft is radially aligned with each protruding apex 1-8. The second row of tufts are located three to seven millimeters longitudinally inward from the first row and are radially aligned with each of the eight base apices B1-B8. Each of the tufts in the second and third rows are five to seven millimeter long.
Polyester tufts are knotted directly onto each helix of the V-shaped lumen piercing members which are located on the outside 306 of the graft 206. The polyester tufts are designed to seal the holes in the graft created by puncturing the hooks 236 of the V-shaped lumen piercing member through the wall of the graft as well as provide a surface covering the apex that can bind to tissue growth of the graft.
Referring now to
Another embodiment of the present invention includes an attachment system that is well adapted to affix a graft into the iliac arteries as illustrated in
Lumen piercing members 348 extend outward from apices D1 and D4 towards said first end 338 and second end 340 of said first wire frame 334 respectively. Similarly, lumen piercing members extend outward from apices D5 and D8 towards said first end 342 and second end of said second wire frame 336 respectively. Each lumen piercing member has a longitudinally outward protruding arm 350 that is approximately one millimeter in length. At the outermost extremity of the lumen piercing member, the arms are bent in a radially outward direction to form hooks which are designed to pierce the lumen to which the graft is being affixed. While the hooks in
The base apices are preferably sewn to the outer extremity of the graft and are spaced equally around the circumference at six points with two pairs of overlapping base apices. Base apex D1 overlaps with base apex D8 when affixed to the graft. Base apex D5 likewise overlaps apex D4.
An important feature of the present invention is how the two wire frames 334 and 336 can be affixed together to cooperate as a single wire frame unit without actually welding the two frames together. The first and second wire frames are affixed together by wrapping the arm 350 of the lumen piercing member around the adjacent struts 352-358 when oriented with the overlapping base apices above. For example, the lumen piercing member on the first end 338 of the first wire frame is wrapped around the strut 352 extending between base apex D8 and protruding apex C6. The lumen piercing member on the second end of the second wire frame is wrapped around the strut 354 extending between base apex D1 and protruding apex C1. The lumen piercing member on the second end 340 of the first wire frame is wrapped around the strut 356 extending between base apex D5 and protruding apex C4. The lumen piercing member on the first end of the second wire frame is wrapped around the strut 358 extending between base apex D4 and protruding apex C3.
By wrapping around, it is meant that the arm 350 of the lumen piercing member 348 makes at least one full twist around the adjacent strut 352-358. It is desirable that the struts rest against the inside edge of the adjacent protruding apices C1-C6. When the arm, after being twisted around the adjacent strut is radially inward from the protruding apex, the spring tension caused by twisting the wire arms together with adjacent struts 352-358 more forcefully biases the arm outward. In some instances, the arm can be further supported by the protruding apex by threading the arm through the eye of the helix of the protruding apex.
As shown in
Referring again to
As viewed in
The crimps 371 can be formed by methods known to one skilled in the art such as heat crimping. A crimp iron (not shown) with a heating desired element that is formed into the general shape of the crimping pattern may be placed into the lumen of the graft 206. The graft is tied radially inward at each pleat 374. Finally, the crimp iron is heated causing permanent crimps in the graft. It must be noted that the length of the graft should be adjusted to offset the longitudinal shrinkage caused by heat crimping the graft. For example, a seventy millimeter crimped graft with crimps along twenty millimeters of the graft must use an uncrimped graft that will have a pre-crimped length of about eighty millimeters.
The crimped configuration in the graft 206 has benefits. The crimps 371 prevent kinking in the graft when the graft is deployed in the lumen of angulated vessels. Uncrimped vessels have a greater tendency to form kinks at the angulations, creating an uneven surface within the vessel. Such kinks will cause more turbulence in the vessel.
Another benefit resulting from adding crimps 371 to the graft 206 is due to the patient's respiratory cycle. Certain blood vessels undergo a length change due to the respiratory cycle. The length change of blood vessels may cause considerable stress on the attachment system implanted into the wall of the blood vessel. Crimping of the graft allows a certain longitudinal flexibility of the graft and blood vessel to reduce the stress exerted upon the attachment system.
One of the considerations when determining whether or not to crimp the graft is the goal of spatially distributing the bulk of the graft and the attachment system longitudinally. Because the crimping substantially increases the radial profile of the graft when in a collapsed position, the amount of crimping must be carefully considered. For example, the graft is not crimped along the portion of the graft that surrounds the attachment system. Also, crimps are placed along the graft at locations which are likely to be placed adjacent an angulation of the vessel.
It will be apparent from the foregoing that, while particular forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3334629||9 Nov 1964||8 Aug 1967||Bertram D Cohn||Occlusive device for inferior vena cava|
|US3494006||12 Jan 1968||10 Feb 1970||George C Brumlik||Self-gripping fastening device|
|US3540431||4 Apr 1968||17 Nov 1970||Kazi Mobin Uddin||Collapsible filter for fluid flowing in closed passageway|
|US3562820||21 Aug 1967||16 Feb 1971||Bernhard Braun||Tubular sheet and strip form prostheses on a basis of biological tissue|
|US3657744||8 May 1970||25 Apr 1972||Univ Minnesota||Method for fixing prosthetic implants in a living body|
|US3834394||23 Feb 1972||10 Sep 1974||J Hunter||Occlusion device and method and apparatus for inserting the same|
|US3874388||12 Feb 1973||1 Apr 1975||Ochsner Med Found Alton||Shunt defect closure system|
|US3908662||6 Jul 1973||30 Sep 1975||Mashinistov Boris Fedorovich||Device for the eversion of hollow organs and vascular stapling instrument incorporating same|
|US3938499||5 Feb 1974||17 Feb 1976||Louis Bucalo||Implant and implanting method and tool|
|US3938528||23 Aug 1973||17 Feb 1976||Investors In Ventures, Inc.||Implanting and splicing articles and methods for living beings|
|US4006747||23 Apr 1975||8 Feb 1977||Ethicon, Inc.||Surgical method|
|US4047252||29 Jan 1976||13 Sep 1977||Meadox Medicals, Inc.||Double-velour synthetic vascular graft|
|US4056854||28 Sep 1976||8 Nov 1977||The United States Of America As Represented By The Department Of Health, Education And Welfare||Aortic heart valve catheter|
|US4198982||31 Mar 1978||22 Apr 1980||Memorial Hospital For Cancer And Allied Diseases||Surgical stapling instrument and method|
|US4300244||19 Sep 1979||17 Nov 1981||Carbomedics, Inc.||Cardiovascular grafts|
|US4323071||19 May 1980||6 Apr 1982||Advanced Catheter Systems, Inc.||Vascular guiding catheter assembly and vascular dilating catheter assembly and a combination thereof and methods of making the same|
|US4351341||15 Aug 1980||28 Sep 1982||Uresil Company||Balloon catheter|
|US4441215||23 Feb 1983||10 Apr 1984||Kaster Robert L||Vascular graft|
|US4503569||3 Mar 1983||12 Mar 1985||Dotter Charles T||Transluminally placed expandable graft prosthesis|
|US4562596||25 Apr 1984||7 Jan 1986||Elliot Kornberg||Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair|
|US4577631||16 Nov 1984||25 Mar 1986||Kreamer Jeffry W||Aneurysm repair apparatus and method|
|US4592754||9 Sep 1983||3 Jun 1986||Gupte Pradeep M||Surgical prosthetic vessel graft and catheter combination and method|
|US4617932||3 Sep 1985||21 Oct 1986||Elliot Kornberg||Device and method for performing an intraluminal abdominal aortic aneurysm repair|
|US4649922||23 Jan 1986||17 Mar 1987||Wiktor Donimik M||Catheter arrangement having a variable diameter tip and spring prosthesis|
|US4655771||11 Apr 1983||7 Apr 1987||Shepherd Patents S.A.||Prosthesis comprising an expansible or contractile tubular body|
|US4662885||3 Sep 1985||5 May 1987||Becton, Dickinson And Company||Percutaneously deliverable intravascular filter prosthesis|
|US4665918||6 Jan 1986||19 May 1987||Garza Gilbert A||Prosthesis system and method|
|US4681110||2 Dec 1985||21 Jul 1987||Wiktor Dominik M||Catheter arrangement having a blood vessel liner, and method of using it|
|US4718907||20 Jun 1985||12 Jan 1988||Atrium Medical Corporation||Vascular prosthesis having fluorinated coating with varying F/C ratio|
|US4728328||3 Jun 1985||1 Mar 1988||Research Corporation||Cuffed tubular organic prostheses|
|US4732152||5 Dec 1985||22 Mar 1988||Medinvent S.A.||Device for implantation and a method of implantation in a vessel using such device|
|US4733665||7 Nov 1985||29 Mar 1988||Expandable Grafts Partnership||Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft|
|US4739762||3 Nov 1986||26 Apr 1988||Expandable Grafts Partnership||Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft|
|US4740207||10 Sep 1986||26 Apr 1988||Kreamer Jeffry W||Intralumenal graft|
|US4771773||30 May 1986||20 Sep 1988||Medinvent S.A.||Insertion device|
|US4776337||26 Jun 1986||11 Oct 1988||Expandable Grafts Partnership||Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft|
|US4787899||10 Dec 1986||29 Nov 1988||Lazarus Harrison M||Intraluminal graft device, system and method|
|US4793348||15 Nov 1986||27 Dec 1988||Palmaz Julio C||Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation|
|US4795458||2 Jul 1987||3 Jan 1989||Regan Barrie F||Stent for use following balloon angioplasty|
|US4817600||22 May 1987||4 Apr 1989||Medi-Tech, Inc.||Implantable filter|
|US4830003||17 Jun 1988||16 May 1989||Wolff Rodney G||Compressive stent and delivery system|
|US4848343||30 Oct 1987||18 Jul 1989||Medinvent S.A.||Device for transluminal implantation|
|US4872874||29 May 1987||10 Oct 1989||Taheri Syde A||Method and apparatus for transarterial aortic graft insertion and implantation|
|US4875480||25 Sep 1987||24 Oct 1989||Medinvent S.A.||Device for transluminal implantation|
|US4878906||6 Jun 1988||7 Nov 1989||Servetus Partnership||Endoprosthesis for repairing a damaged vessel|
|US4954126||28 Mar 1989||4 Sep 1990||Shepherd Patents S.A.||Prosthesis comprising an expansible or contractile tubular body|
|US4969890||7 Jul 1988||13 Nov 1990||Nippon Zeon Co., Ltd.||Catheter|
|US4994032||29 Nov 1988||19 Feb 1991||Terumo Kabushiki Kaisha||Balloon catheter|
|US4994069||2 Nov 1988||19 Feb 1991||Target Therapeutics||Vaso-occlusion coil and method|
|US4994071||22 May 1989||19 Feb 1991||Cordis Corporation||Bifurcating stent apparatus and method|
|US5024671||19 Sep 1988||18 Jun 1991||Baxter International Inc.||Microporous vascular graft|
|US5037427||30 Oct 1990||6 Aug 1991||Terumo Kabushiki Kaisha||Method of implanting a stent within a tubular organ of a living body and of removing same|
|US5041126||14 Sep 1988||20 Aug 1991||Cook Incorporated||Endovascular stent and delivery system|
|US5066298||30 Nov 1989||19 Nov 1991||Progressive Angioplasty Systems, Inc.||Article and method of sheathing angioplasty balloons|
|US5084065||10 Jul 1989||28 Jan 1992||Corvita Corporation||Reinforced graft assembly|
|US5102417||28 Mar 1988||7 Apr 1992||Expandable Grafts Partnership|
|US5104399||9 Mar 1988||14 Apr 1992||Endovascular Technologies, Inc.||Artificial graft and implantation method|
|US5104402||20 Mar 1990||14 Apr 1992||Trustees Of The University Of Pennsylvania||Prosthetic vessels for stress at vascular graft anastomoses|
|US6099558 *||10 Nov 1996||8 Aug 2000||Edwards Lifesciences Corp.||Intraluminal grafting of a bifuricated artery|
|US6221102 *||7 Jun 1995||24 Apr 2001||Endovascular Technologies, Inc.||Intraluminal grafting system|
|US6241760 *||25 Mar 1997||5 Jun 2001||G. David Jang||Intravascular stent|
|EP0150281A1||8 Nov 1984||7 Aug 1985||Medi-Tech, Incorporated||Medical introducer-catheter system|
|EP0461791A1||3 Jun 1991||18 Dec 1991||Hector D. Barone||Aortic graft and apparatus for repairing an abdominal aortic aneurysm|
|SU660689A1||Title not available|
|SU1217402A1||Title not available|
|WO1990015582A1||15 Jun 1990||27 Dec 1990||Trout Hugh H Iii||Aortic graft and method for repairing aneurysm|
|1||Advertising Flyer for Greenfield Vena Cava Filter a Product of Medi-Tech, Inc. of Watertown, Massachusetts Illustrates a Stainless Steel Device for Interluminal Placement Configured to Prevent Pulmonary Embolism.|
|2||Andrew Cragg et al., "Nonsurgical Placement of Arterial Endoprostheses: A New Technique Using Nitinol Wire", Radiology, 147:261-263, Apr. 1983.|
|3||Balko et al., "Transfemoral Placement of Intraluminal Polyurethane Prosthesis for Abd. Aortic Aneurysm", Jour. Surg. Res., 40:305-309 (1986).|
|4||Charnsangavej et al., "Endovascular Stent for Use in Aortic Dissection: An in Vitro Experiment", Radiology, 157:323-324.|
|5||Charnsangavej, et al., "Endovascular Stent for Use in Aortic Dissection: An in Vitro Experiment", Radiology, 1985:323-324, 1985.|
|6||Charnsangavej, et al., "Stenosis of the Vena Cava: Preliminary Assessment of Treatment with Expandable Metallic Stents", Radiology 1986; 161:295-298, 1986.|
|7||Charnsangavey et al., "Stenosis of the Vena Cava: Preliminary Assessment of Treatment With Expandable Metallic Stents", Radiology, vol. 161, pp. 295-298.|
|8||D. Maass, "Radiological Follow-Up of Transluminally Inserted Vascular Endoprosthesis, An Experimental Study Using Expanding Spirals", Radiology 152:659-663 (1984).|
|9||D. Muller et al., "Advances in coronary angioplasty: endovascular stents," Coronary Artery Disease, Jul./Aug. 1990, vol. 1, No. 4.|
|10||Dotter et al., "Transluminal Expandible Nitinol", Radiology, 147:259-260, Apr. 1983.|
|11||Kaj Johansen, "Aneurysms", Scientific American, 247:110-125, Jul. 1982.|
|12||Krause et al., "Early Experience with the Interluminal Graft Prosthesis", Amer. Jour. of Surgery, 145:619-622, May 1983.|
|13||M. Matsumae et al., "An experimental study of a new sutureless intraluminal graft with an elastic ring that can attach itself to the vessel wall," Journal of Vascular Surgery, vol. 8 No. 1, pp. 38-44, Jul. 1988.|
|14||Rosch et al., "Experimental Intrahepatic Portacaval Anastomosis: Use of Expandable Gianturco Stents", Radiology, 162:481-485.|
|15||Rosch et al., "Gianturco Expandable Wire Stents in the Treatment of Superior Vena Cava Syndrome Recurring After Maximum-Tolerance Radiation", Cancer, vol. 60, No. 6, Sep. 15, 1987, pp. 1243-1246.|
|16||Rösch, et al., "Experimental Intrahepatic Portacaval Anastomosis: Use of Expandable Gianturco Stents", Radiology 1987: 162:481-485, 1987.|
|17||Rösch, et al., "Gianturco Expandable Wire Stents in the Treatment of Superior Vena Cava Syndrome Recurring After Maximum-Tolerance Radiation", Cancer 60:1243-1246, 1987.|
|18||S. Wong et al., "An Update on Coronary Stents," Cardio, Feb. 1992.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7763063||2 Jul 2004||27 Jul 2010||Bolton Medical, Inc.||Self-aligning stent graft delivery system, kit, and method|
|US7905915 *||23 Dec 2008||15 Mar 2011||Cook Incorporated||Z-stent with incorporated barbs|
|US8007605||30 Jan 2007||30 Aug 2011||Bolton Medical, Inc.||Method of forming a non-circular stent|
|US8062345||26 Jul 2007||22 Nov 2011||Bolton Medical, Inc.||Delivery systems for delivering and deploying stent grafts|
|US8062349||31 Jan 2007||22 Nov 2011||Bolton Medical, Inc.||Method for aligning a stent graft delivery system|
|US8070790||13 Feb 2006||6 Dec 2011||Bolton Medical, Inc.||Capture device for stent graft delivery|
|US8147534||25 May 2005||3 Apr 2012||Tyco Healthcare Group Lp||System and method for delivering and deploying an occluding device within a vessel|
|US8163007 *||2 Feb 2009||24 Apr 2012||Cook Medical Technologies Llc||Stent designs for use with one or more trigger wires|
|US8167927||26 Sep 2011||1 May 2012||Trivascular, Inc.||Barbed radially expandable stent|
|US8226701||26 Sep 2007||24 Jul 2012||Trivascular, Inc.||Stent and delivery system for deployment thereof|
|US8236042||8 Apr 2009||7 Aug 2012||Tyco Healthcare Group Lp||System and method for delivering and deploying an occluding device within a vessel|
|US8241346||27 Sep 2011||14 Aug 2012||Trivascular, Inc.||Endovascular graft and method of delivery|
|US8252036||31 Jul 2007||28 Aug 2012||Syntheon Cardiology, Llc||Sealable endovascular implants and methods for their use|
|US8257421||6 Apr 2009||4 Sep 2012||Tyco Healthcare Group Lp||System and method for delivering and deploying an occluding device within a vessel|
|US8267985||24 May 2006||18 Sep 2012||Tyco Healthcare Group Lp||System and method for delivering and deploying an occluding device within a vessel|
|US8273101||20 Apr 2009||25 Sep 2012||Tyco Healthcare Group Lp||System and method for delivering and deploying an occluding device within a vessel|
|US8292943||23 Feb 2004||23 Oct 2012||Bolton Medical, Inc.||Stent graft with longitudinal support member|
|US8308790||6 Feb 2006||13 Nov 2012||Bolton Medical, Inc.||Two-part expanding stent graft delivery system|
|US8328861||16 Nov 2007||11 Dec 2012||Trivascular, Inc.||Delivery system and method for bifurcated graft|
|US8382825||10 Mar 2011||26 Feb 2013||Covidien Lp||Flexible vascular occluding device|
|US8394119||28 Feb 2012||12 Mar 2013||Covidien Lp||Stents having radiopaque mesh|
|US8398701||25 May 2005||19 Mar 2013||Covidien Lp||Flexible vascular occluding device|
|US8449595||14 Nov 2011||28 May 2013||Bolton Medical, Inc.||Delivery systems for delivering and deploying stent grafts|
|US8500792||31 Mar 2009||6 Aug 2013||Bolton Medical, Inc.||Dual capture device for stent graft delivery system and method for capturing a stent graft|
|US8617234||24 May 2006||31 Dec 2013||Covidien Lp||Flexible vascular occluding device|
|US8623067||17 Apr 2009||7 Jan 2014||Covidien Lp||Methods and apparatus for luminal stenting|
|US8628564||17 Apr 2009||14 Jan 2014||Covidien Lp||Methods and apparatus for luminal stenting|
|US8636760||28 Aug 2012||28 Jan 2014||Covidien Lp||System and method for delivering and deploying an occluding device within a vessel|
|US8636788||3 Aug 2012||28 Jan 2014||Bolton Medical, Inc.||Methods of implanting a prosthesis|
|US8663309 *||26 Sep 2007||4 Mar 2014||Trivascular, Inc.||Asymmetric stent apparatus and method|
|US8740963||8 Jun 2006||3 Jun 2014||Bolton Medical, Inc.||Methods of implanting a prosthesis and treating an aneurysm|
|US8864814||27 Sep 2011||21 Oct 2014||Trivascular, Inc.||Method of delivering advanced endovascular graft and system|
|US8992595||13 Mar 2013||31 Mar 2015||Trivascular, Inc.||Durable stent graft with tapered struts and stable delivery methods and devices|
|US8998970||14 Mar 2013||7 Apr 2015||Bolton Medical, Inc.||Vascular prosthetic delivery device and method of use|
|US8999364||25 May 2007||7 Apr 2015||Nanyang Technological University||Implantable article, method of forming same and method for reducing thrombogenicity|
|US9050205||20 Jul 2012||9 Jun 2015||Covidien Lp||Methods and apparatus for luminal stenting|
|US9095343||29 Feb 2012||4 Aug 2015||Covidien Lp||System and method for delivering and deploying an occluding device within a vessel|
|US9101506||12 Mar 2010||11 Aug 2015||Bolton Medical, Inc.||System and method for deploying an endoluminal prosthesis at a surgical site|
|US9114001||14 Mar 2013||25 Aug 2015||Covidien Lp||Systems for attaining a predetermined porosity of a vascular device|
|US9125659||18 Mar 2013||8 Sep 2015||Covidien Lp||Flexible vascular occluding device|
|US9138335||9 Jul 2012||22 Sep 2015||Syntheon Cardiology, Llc||Surgical implant devices and methods for their manufacture and use|
|US9155647||18 Jul 2012||13 Oct 2015||Covidien Lp||Methods and apparatus for luminal stenting|
|US9157174||14 Mar 2013||13 Oct 2015||Covidien Lp||Vascular device for aneurysm treatment and providing blood flow into a perforator vessel|
|US9173755||5 Dec 2011||3 Nov 2015||Bolton Medical, Inc.||Vascular repair devices|
|US9192500||22 Jun 2015||24 Nov 2015||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9198666||16 Jul 2012||1 Dec 2015||Covidien Lp||System and method for delivering and deploying an occluding device within a vessel|
|US9198786||1 Feb 2007||1 Dec 2015||Bolton Medical, Inc.||Lumen repair device with capture structure|
|US9204983||28 Aug 2012||8 Dec 2015||Covidien Lp||System and method for delivering and deploying an occluding device within a vessel|
|US9220617||10 Jun 2014||29 Dec 2015||Bolton Medical, Inc.||Dual capture device for stent graft delivery system and method for capturing a stent graft|
|US9295568||17 Sep 2013||29 Mar 2016||Covidien Lp||Methods and apparatus for luminal stenting|
|US9301831||14 Mar 2013||5 Apr 2016||Covidien Lp||Methods for attaining a predetermined porosity of a vascular device|
|US9320590||11 Mar 2013||26 Apr 2016||Covidien Lp||Stents having radiopaque mesh|
|US9320631||31 Jan 2007||26 Apr 2016||Bolton Medical, Inc.||Aligning device for stent graft delivery system|
|US9320632||6 Nov 2015||26 Apr 2016||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9333104||22 May 2013||10 May 2016||Bolton Medical, Inc.||Delivery systems for delivering and deploying stent grafts|
|US9345603||6 Nov 2015||24 May 2016||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9364314||30 Jun 2009||14 Jun 2016||Bolton Medical, Inc.||Abdominal aortic aneurysms: systems and methods of use|
|US9375327||3 Jun 2011||28 Jun 2016||Intact Vascular, Inc.||Endovascular implant|
|US9375336||12 Mar 2015||28 Jun 2016||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9375337||16 Oct 2015||28 Jun 2016||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9381104||16 Jul 2012||5 Jul 2016||Covidien Lp||System and method for delivering and deploying an occluding device within a vessel|
|US9393021||25 Feb 2013||19 Jul 2016||Covidien Lp||Flexible vascular occluding device|
|US9408607||24 Jun 2010||9 Aug 2016||Edwards Lifesciences Cardiaq Llc||Surgical implant devices and methods for their manufacture and use|
|US9408734||13 Dec 2013||9 Aug 2016||Bolton Medical, Inc.||Methods of implanting a prosthesis|
|US9408735||16 Jan 2014||9 Aug 2016||Bolton Medical, Inc.||Methods of implanting a prosthesis and treating an aneurysm|
|US9433520||19 Jan 2016||6 Sep 2016||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9439751||15 Mar 2013||13 Sep 2016||Bolton Medical, Inc.||Hemostasis valve and delivery systems|
|US9445929||6 Nov 2015||20 Sep 2016||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9452070||31 Oct 2012||27 Sep 2016||Covidien Lp||Methods and systems for increasing a density of a region of a vascular device|
|US9456914||29 Jan 2016||4 Oct 2016||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9498363||15 Mar 2013||22 Nov 2016||Trivascular, Inc.||Delivery catheter for endovascular device|
|US9545322||1 Mar 2011||17 Jan 2017||Intact Vascular, Inc.||Device and method for tacking plaque to blood vessel wall|
|US9554929||5 Mar 2015||31 Jan 2017||Bolton Medical, Inc.||Vascular prosthetic delivery device and method of use|
|US9561122||6 Oct 2015||7 Feb 2017||Covidien Lp||Vascular device for aneurysm treatment and providing blood flow into a perforator vessel|
|US9561124||20 Jul 2010||7 Feb 2017||Bolton Medical, Inc.||Methods of self-aligning stent grafts|
|US9566178||21 Oct 2012||14 Feb 2017||Edwards Lifesciences Cardiaq Llc||Actively controllable stent, stent graft, heart valve and method of controlling same|
|US9584777||19 Apr 2016||28 Feb 2017||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9585743||28 Dec 2011||7 Mar 2017||Edwards Lifesciences Cardiaq Llc||Surgical implant devices and methods for their manufacture and use|
|US9585782||20 Apr 2016||7 Mar 2017||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9602786||20 Apr 2016||21 Mar 2017||Intact Vascular, Inc.||Delivery device and method of delivery|
|US9603730||25 Nov 2013||28 Mar 2017||Intact Vascular, Inc.||Endoluminal device and method|
|US9610181||25 Apr 2016||4 Apr 2017||Covidien Lp||Stents having radiopaque mesh|
|US9655712||10 Feb 2016||23 May 2017||Bolton Medical, Inc.||Vascular repair devices|
|US9675482||13 May 2009||13 Jun 2017||Covidien Lp||Braid implant delivery systems|
|US9730818||24 Jan 2013||15 Aug 2017||Intact Vascular, Inc.||Endoluminal device and method|
|US20050049667 *||2 Jul 2004||3 Mar 2005||Bolton Medical, Inc.||Self-aligning stent graft delivery system, kit, and method|
|US20060129224 *||6 Feb 2006||15 Jun 2006||Bolton Medical, Inc.||Two-part expanding stent graft delivery system|
|US20060188408 *||13 Feb 2006||24 Aug 2006||Bolton Medical, Inc.||Capture device for stent graft delivery|
|US20060206200 *||24 May 2006||14 Sep 2006||Chestnut Medical Technologies, Inc.||Flexible vascular occluding device|
|US20060206201 *||24 May 2006||14 Sep 2006||Chestnut Medical Technologies, Inc.||Flexible vascular occluding device|
|US20070135818 *||31 Jan 2007||14 Jun 2007||Bolton Medical, Inc.||Aligning device for stent graft delivery system|
|US20070135889 *||1 Feb 2007||14 Jun 2007||Bolton Medical, Inc.||Lumen repair device with capture structure|
|US20070142894 *||31 Jan 2007||21 Jun 2007||Bolton Medical, Inc.||Method for aligning a stent graft delivery system|
|US20070163668 *||30 Jan 2007||19 Jul 2007||Bolton Medical, Inc.||Method of forming a non-circular stent|
|US20070198078 *||1 Feb 2007||23 Aug 2007||Bolton Medical, Inc.||Delivery system and method for self-centering a Proximal end of a stent graft|
|US20080097620 *||25 May 2007||24 Apr 2008||Nanyang Technological University||Implantable article, method of forming same and method for reducing thrombogenicity|
|US20090005760 *||31 Jul 2007||1 Jan 2009||Richard George Cartledge||Sealable endovascular implants and methods for their use|
|US20090082841 *||26 Sep 2007||26 Mar 2009||Boston Scientific Corporation||Apparatus for securing stent barbs|
|US20090082842 *||26 Sep 2007||26 Mar 2009||Boston Scientific Corporation||Stent and delivery system for deployment thereof|
|US20090082845 *||26 Sep 2007||26 Mar 2009||Boston Scientific Corporation||Alignment stent apparatus and method|
|US20090082846 *||26 Sep 2007||26 Mar 2009||Boston Scientific Corporation||Asymmetric stent apparatus and method|
|US20090082847 *||26 Sep 2007||26 Mar 2009||Boston Scientific Corporation||System and method of securing stent barbs|
|US20090099649 *||3 Oct 2008||16 Apr 2009||Chobotov Michael V||Modular vascular graft for low profile percutaneous delivery|
|US20090132026 *||16 Nov 2007||21 May 2009||Boston Scientific Corporation||Delivery system and method for bifurcated graft|
|US20090171442 *||23 Dec 2008||2 Jul 2009||Cook Incorporated||Z-stent with incorporated barbs|
|US20090204202 *||2 Feb 2009||13 Aug 2009||William Cook Australia Pty. Ltd.||Stent designs for use with one or more trigger wires|
|US20090287241 *||17 Apr 2009||19 Nov 2009||Chestnut Medical Technologies, Inc.||Methods and apparatus for luminal stenting|
|US20090287288 *||17 Apr 2009||19 Nov 2009||Chestnut Medical Technologies, Inc.||Methods and apparatus for luminal stenting|
|US20090287292 *||13 May 2009||19 Nov 2009||Becking Frank P||Braid Implant Delivery Systems|
|US20100030318 *||31 Mar 2009||4 Feb 2010||Bolton Medical, Inc.||Dual Capture Device for Stent Graft Delivery System and Method for Capturing a Stent Graft|
|US20100234932 *||12 Mar 2010||16 Sep 2010||Bolton Medical, Inc.||System and method for deploying an endoluminal prosthesis at a surgical site|
|US20100331958 *||19 Dec 2008||30 Dec 2010||Trivascular, Inc.||Hinged endovascular device|
|US20110004237 *||29 May 2010||6 Jan 2011||Peter Schneider||Minimal surface area contact device for holding plaque to blood vessel wall|
|US20110093060 *||24 Jun 2010||21 Apr 2011||Cartledge Richard G||Surgical Implant Devices and Methods for their Manufacture and Use|
|US20110166592 *||10 Mar 2011||7 Jul 2011||Chestnut Medical Technologies, Inc.||Flexible vascular occluding device|
|US20110218607 *||20 Jul 2010||8 Sep 2011||Samuel Arbefeuille||Methods of Self-Aligning Stent Grafts|
|US20110218609 *||9 Feb 2011||8 Sep 2011||Trivascular, Inc.||Fill tube manifold and delivery methods for endovascular graft|
|US20110218617 *||2 Mar 2011||8 Sep 2011||Endologix, Inc.||Endoluminal vascular prosthesis|
|US20140135899 *||16 Jan 2014||15 May 2014||Trivascular, Inc.||Asymmetric stent apparatus and method|
|U.S. Classification||623/1.36, 623/1.14|
|International Classification||A61F2/04, A61F2/82, A61F2/00, A61B17/11|
|Cooperative Classification||A61M25/10, A61M2025/1068, A61F2002/075, A61F2/04, A61F2002/30451, A61F2250/0098, A61F2/82, A61B17/11, A61F2002/3008, A61F2002/8486, A61F2/07, A61F2220/0058, A61F2/958, A61F2/848, A61F2/89, A61F2230/0054, A61F2220/0075, A61F2220/005, A61F2220/0016|
|European Classification||A61F2/958, A61F2/07, A61F2/82, A61B17/11, A61F2/04, A61M25/10|
|1 May 2007||CC||Certificate of correction|
|30 Aug 2010||REMI||Maintenance fee reminder mailed|
|23 Jan 2011||LAPS||Lapse for failure to pay maintenance fees|
|15 Mar 2011||FP||Expired due to failure to pay maintenance fee|
Effective date: 20110123
|11 Mar 2013||AS||Assignment|
Owner name: ACACIA RESEARCH GROUP LLC, TEXAS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ENDOVASCULAR TECHNOLOGIES, INC.;REEL/FRAME:029967/0144
Effective date: 20121220
|14 Mar 2013||AS||Assignment|
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACACIA RESEARCH GROUP LLC;REEL/FRAME:030003/0055
Owner name: LIFEPORT SCIENCES LLC, TEXAS
Effective date: 20121227